"✅Somos un Centro dedicado a la Investigación clínica, fundado en el año 2.003. Contribuimos en el desarrollo de nuevas y mejores opciones de tratamiento en distintas áreas terapéuticas, destacándose las siguientes: diabetes mellitus, osteoporosis, trastornos de lípidos, riesgo cardiovascular, menopausia, patologías reumatológicas, trastornos cognitivos y demencias, entre otros. ✅Para este propósito contamos con un equipo humano multidisciplinario altamente comprometido, capacitado, involucrado y en búsqueda del mejoramiento continuo. ✅Cumplimos la normatividad nacional e internacional de las Buenas Prácticas Clínicas para brindar una atención de alta calidad científica, humanizada y segura."

During the past decade, Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo" #1 collaborator was "Novartis" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo" are "Migraine" (2 trials), "Evaluate the Safety and Efficacy of Denosumab in Pediatric Subjects With" (1 trials), "Glucocorticoid-induced Osteoporosis" (1 trials) and "Overactive Bladder" (1 trials). Many other conditions were trialed in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo" in a lesser frequency.

Most popular intervention types in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo" are "Drug" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "Denosumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Solano y Terront Servicios Medicos Ltda - Unidad Integral de Endocrinologia Uniendo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".